Sponsored message
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
  • Listen Now Playing Listen
NPR News

What we know about the Omicron variant and the pandemic in South Africa

South Africa has accelerated its vaccination campaign a week after the discovery of the omicron variant of the coronavirus. (AP Photo/Jerome Delay)
South Africa has accelerated its vaccination campaign a week after the discovery of the omicron variant of the coronavirus. (AP Photo/Jerome Delay)

You value independent local news, so become a sustainer today to power our newsroom.

Listen 47:27

Sophisticated disease surveillance led South Africa to first report the Omicron variant to the world.

But instead of celebration, they’ve been met with restrictions.

“The concern here is that you know a country like South Africa did exactly what it should have under those international health regulations,” Dr. Nahid Bhadelia, founding director of the BU Center for Emerging Infectious Diseases Policy and Research, says. “And then they were punished for exactly that.”

Meanwhile, the rise of the Omicron variant has led to a surge of COVID cases across the country.

And while public health experts in South Africa can track the disease and identify new variants, they haven’t had as much success regarding vaccination rates.

“A lot of the things we’re seeing coming out now about the COVID vaccines, we have actually seen for other vaccines in the past,” researcher Sarah Downs says. “It’s just now with COVID vaccines, rolling out the vaccine to an entire population is something we’ve never actually had to do before.”

Today, On Point: South Africa and the COVID pandemic.

Sponsored message

Guests

Vicky Baillie, senior scientist at the Wits Vaccines & Infectious Diseases Analytics Research Unit in South Africa.

Salim Abdool Karim, professor of global health in the department of epidemiology at Columbia University. Former co-chair of South Africa’s Ministerial Advisory Committee on COVID-19. (@ProfAbdoolKarim)

Also Featured

Sarah Downs, PhD fellow at the University of Witwatersrand. (@TheSecretSarah)

Nahid Bhadelia, founding director of BU Center for Emerging Infectious Diseases Policy and Research. Associate director of the National Emerging Infectious Diseases Laboratories (NEIDL). (@BhadeliaMD)

From The Reading List

Sponsored message

Business Insider: “Southern Africa is not a hotbed of variants — it’s just very good at sequencing and spotting them” — “Last week, scientists in South Africa put the world on notice. Omicron is here.”

The Lancet: “Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic” — “On Nov 25, 2021, about 23 months since the first reported case of COVID-19 and after a global estimated 260 million cases and 5·2 million deaths, a new SARS-CoV-2 variant of concern (VoC), omicron  was reported.”

This article was originally published on WBUR.org.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

You come to LAist because you want independent reporting and trustworthy local information. Our newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our connected community. We are free to tell the full truth, to hold power to account without fear or favor, and to follow facts wherever they lead. Our only loyalty is to our audiences and our mission: to inform, engage, and strengthen our community.

Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive from readers like you will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.

If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.

Your tax-deductible donation keeps LAist independent and accessible to everyone.
Senior Vice President News, Editor in Chief

Make your tax-deductible donation today